Attached files
file | filename |
---|---|
8-K - FORM 8-K - AXON ENTERPRISE, INC. | c13071e8vk.htm |
EXHIBIT 99.1
FOR RELEASE ON: February 23, 2011 at 7:30 a.m. ET
CONTACT: | Dan Behrendt Chief Financial Officer TASER International, Inc. (480) 905-2000 |
TASER International Reports Fourth Quarter Results
Company Generates $3.2 Million in Cash on $22.9 Million in Revenue
SCOTTSDALE, Ariz., February 23, 2011 TASER International, Inc. (NASDAQ: TASR), today announced
financial results for the fourth quarter and year ended December 31, 2010.
Q4 2010 Financial Summary:
| Net sales were $22.9 million in the quarter, a decrease of $8.1 million or 26.3%
compared to fourth quarter 2009 sales of $31.0 million on an adjusted basis. Prior year
fourth quarter sales were increased by $3.5 million from the recognition of deferred
revenue related to the TASER® X26 Electronic Control Device (ECD) trade-in
program, which was introduced with the launch of the TASER® X3 product. The
decrease in net sales was driven by fewer individually significant orders from domestic and
international law enforcement and military customers. |
| Gross margin declined to 51.7% in the fourth quarter of 2010, compared to 59.0% on an
adjusted basis, in the same period last year. The decline was primarily attributed to a
reduced leverage on indirect manufacturing expenses due to the decrease in sales. Following
the official launch of Evidence.com, data center operating and software maintenance costs
are included in cost of sales, which reduced gross margin as a percent of sales by 4.8%
(from 56.5% before data center operations and software maintenance to 51.7% net). |
| Sales, general and administrative (SG&A) expenses of $9.3 million in the fourth quarter
of 2010 decreased 5%, or $0.5 million, compared to the fourth quarter of 2009, a result of
tighter cost-control measures implemented by the Company in 2010. |
| Research and development (R&D) expenses decreased $2.2 million to $2.5 million in the
fourth quarter of 2010, a 47% decrease from the same period last year. The reduction is
partially attributed to costs in the prior year for the AXON product as well as the impact
of cost reduction measures. Additionally, the launch of Evidence.com resulted in the
Company including $1.1 million of expenses in cost of products sold for ongoing delivery
and maintenance of the product, which were previously included in R&D. |
| Adjusted operating income, which excludes the impact of stock-based compensation
charges and depreciation and amortization, was $2.9 million for the fourth quarter of 2010,
a $3.3 million decrease from adjusted operating income of $6.2 million in the fourth
quarter of 2009. GAAP loss from operations was $31,000 for the quarter, compared to income
from operations of $7.2 million for the fourth quarter of 2009. |
| Net loss for the fourth quarter of 2010 was $0.2 million, representing a $(0.00) net
loss per share on a basic and diluted basis. |
| The Company generated $3.2 million in cash from operating activities in the fourth
quarter and $0.8 million for the year. Year-end cash and cash equivalents were $42.7
million and the company maintained no debt on its balance sheet. |
Significant events in the fourth quarter of 2010 included the following:
| The Company recorded a significant order to ship 1000 TASER X3 ECDs and related
accessories from the Arizona Department of Public Safety (DPS). This order represents the
largest single purchase of TASER X3 ECDs and is considered full deployment by the Arizona
DPS. |
In 2010, we made significant investments to execute on our strategy of becoming a full
solutions-provider to our customers, commented Rick Smith, CEO of TASER International, Inc. We
advanced on our strategic objectives of expanding our customer base domestically and
internationally, investing in our people and technology, and developing new product offerings. With
the introduction of AXON and Evidence.com, we created a new market that incorporates our strengths
in hardware with our investments in software technology to capture even more market share. We
believe these investments will yield significant long-term shareholder value. In 2011 we expect a
slowly improving economy, our disciplined cost structure and our unique product offerings to drive
further improvement in our results.
The Company will host its fourth quarter 2010 earnings conference call on Wednesday, February 23,
2011 at 10:00 a.m. ET. To access the audio teleconference, please dial: 1-866-804-6929 or
1-857-350-1675 for international callers. The pass code is 65981446 for both numbers.
Non-GAAP Measures
To supplement the Companys Statements of Operations presented in accordance with GAAP, we are
presenting non-GAAP measures of certain components of financial performance. We have presented
these measures for our investors to be better able to compare our current results with those of
previous periods and have shown a reconciliation of GAAP to the non-GAAP financial measures in the
tables at the end of this release. These non-GAAP measures include the impact of non-cash
stock-based compensation expense, depreciation and amortization. We use these non-GAAP financial
measures for financial and operational decision making and as a means to evaluate period-to-period
comparisons. Our management believes that these non-GAAP financial measures provide meaningful
supplemental information regarding our performance by excluding certain expenses and expenditures
that may not be indicative of our recurring core business operating results, meaning our
operating performance excluding non-cash charges, such as stock-based compensation, depreciation
and amortization and other discrete charges that are infrequent in nature. We believe that both
management and investors benefit from referring to these non-GAAP financial measures in assessing
our performance and when planning, forecasting and analyzing future periods. These non-GAAP
financial measures also facilitate managements internal comparisons to our historical performance
and liquidity.
Caution on Use of Non-GAAP Measures
As noted previously, these non-GAAP financial measures are not consistent with GAAP because they do
not reflect the impact of other non-cash charges. Management believes investors will benefit from
greater transparency in referring to these non-GAAP financial measures when assessing the Companys
operating results, as well as when forecasting and analyzing future periods. However, management
recognizes that:
| these non-GAAP financial measures are limited in their usefulness and
should be considered only as a supplement to the Companys GAAP
financial measures; |
|
| these non-GAAP financial measures should not be considered in
isolation from, or as a substitute for, the Companys GAAP financial
measures; |
| these non-GAAP financial measures should not be considered to be
superior to the Companys GAAP financial measures; and |
|
| these non-GAAP financial measures were not prepared in accordance with
GAAP and investors should not assume that the non-GAAP financial
measures presented in this earnings release were prepared under a
comprehensive set of rules or principles. |
Further, these non-GAAP financial measures may be unique to the Company, as they may be different
from non-GAAP financial measures used by other companies. As such, this presentation of non-GAAP
financial measures may not enhance the comparability of the Companys results to the results of
other companies.
A reconciliation of each non-GAAP financial measure to the most directly comparable GAAP financial
measure or measures appears at the end of this press release.
About TASER International, Inc.
TASER International, Inc., (Nasdaq:TASR) is a global provider of safety technologies that
prevent conflict and protect life. More than 16,000 public safety agencies in 40 countries rely on
TASER electronic control devices (ECDs) and AXON on-officer camera systems to help protect
and serve. TASER innovations benefit individuals and families too; providing personal protection
and accountability while maintaining regard for life. Since 1994, more than 230,000 individuals
have relied on TASER technology as a means for effective personal safety. Learn more about TASER
International and its solutions at www.TASER.com, www.Evidence.com and
www.Protector.com or by calling (800) 978-2737. Be a part of the TASER community by
joining us on Facebook, Twitter and YouTube.
Note to Investors
To review the TASER International Safe Harbor Statement, please visit our Investor Relations Safe
Harbor Statement at www.TASER.com/safeharbor.
This press release contains forward-looking statements within the meaning of Section 27A of
the Securities Act of 1933, as amended (the Securities Act), and Section 21E of the Securities
Exchange Act of 1934, as amended (the Exchange Act), including statements, without limitation,
regarding our expectations, beliefs, intentions or strategies regarding the future. We intend that
such forward-looking statements be subject to the safe-harbor provided by the Private Securities
Litigation Reform Act of 1995. The forward-looking information is based upon current information
and expectations regarding TASER International, Inc. These estimates and statements speak only as
of the date on which they are made, are not guarantees of future performance, and involve certain
risks, uncertainties and assumptions that are difficult to predict. Such forward-looking
statements relate to: expected revenue and earnings growth; estimations regarding the size of our
target markets; successful penetration of the law enforcement market; expansion of product sales to
the private security, military and consumer self-defense markets; growth expectations for new and
existing accounts; expansion of production capability; new product introductions; product safety
and our business model. We caution that these statements are qualified by important factors that
could cause actual results to differ materially from those reflected by the forward-looking
statements herein.
TASER International assumes no obligation to update the information contained in this press
release. These statements are qualified by important factors that could cause our actual results
to differ materially from those reflected by the forward-looking statements. Such factors include
but are not limited to: (1) market acceptance of our products; (2) our ability to establish and
expand direct and indirect distribution channels; (3) our ability to attract and retain the
endorsement of key opinion-leaders in the law enforcement community; (4) the level of product
technology and price competition for our products; (5) the degree and rate of growth of the markets
in which we compete and the accompanying demand for our products; (6) risks associated with rapid
technological change and new product introductions; (7) competition; (8) litigation including
lawsuits resulting from alleged product related injuries and death; (9) media publicity concerning
allegations of deaths and injuries occurring after use of the TASER device and the negative effect
this publicity could have on our sales; (10) TASER device tests and reports; (11) product quality;
(12) implementation of manufacturing automation; (13) potential fluctuations in our quarterly
operating results; (14) financial and budgetary constraints of prospects and customers; (15)
potential delays in international and domestics orders; (16) dependence upon sole and limited
source suppliers; (17) negative reports concerning the TASER device; (18) fluctuations in component
pricing; (19) government regulations and inquiries; (20) dependence upon key employees and our
ability to retain employees; (21) execution and implementation risks of new technology; (22)
ramping manufacturing production to meet demand; (23) medical and safety studies; (24) field test
results; and (25) other factors detailed in our filings with the Securities and Exchange
Commission, including, without limitation, those factors detailed in the Companys Annual Report on
Form 10-K and its Quarterly Reports on Form 10-Q.
For investor relations information please contact Katie Pyra by phone at 480-515-6330 or via email
at IR@TASER.com, or Dan Behrendt, Chief Financial Officer of TASER International, Inc.,
480-905-2002.
- more -
TASER International, Inc.
Consolidated Statements of Operations
(Unaudited)
Consolidated Statements of Operations
(Unaudited)
For the Three Months Ended | ||||||||
December 31, 2010 | December 31, 2009 | |||||||
Net Sales |
$ | 22,881,512 | 34,502,925 | |||||
Cost of Products Sold |
11,043,252 | 12,735,946 | ||||||
Gross Margin |
11,838,260 | 21,766,979 | ||||||
Sales, general and administrative expenses |
9,337,920 | 9,789,544 | ||||||
Research and development expenses |
2,530,862 | 4,753,947 | ||||||
Income (loss) from operations |
(30,522 | ) | 7,223,488 | |||||
Interest and other income, net |
1,353 | 8,502 | ||||||
Income (loss) before provision for income taxes |
(29,170 | ) | 7,231,990 | |||||
Provision for income taxes |
167,793 | 2,865,917 | ||||||
Net Income (loss) |
$ | (196,963 | ) | 4,366,073 | ||||
Income (loss) per common and common equivalent shares |
||||||||
Basic |
$ | (0.00 | ) | $ | 0.07 | |||
Diluted |
$ | (0.00 | ) | $ | 0.07 | |||
Weighted average number of common and common equivalent shares outstanding |
||||||||
Basic |
62,346,388 | 62,006,804 | ||||||
Diluted |
62,346,388 | 63,262,151 |
TASER International, Inc.
Consolidated Statements of Operations
(Unaudited)
Consolidated Statements of Operations
(Unaudited)
For the Twelve Months Ended | ||||||||
December 31, 2010 | December 31, 2009 | |||||||
Net Sales |
$ | 86,930,019 | $ | 104,251,560 | ||||
Cost of Products Sold |
41,563,144 | 40,849,151 | ||||||
Gross Margin |
45,366,875 | 63,402,409 | ||||||
Sales, general and administrative expenses |
39,094,625 | 43,479,232 | ||||||
Research and development expenses |
11,411,889 | 20,002,351 | ||||||
Loss from operations |
(5,139,639 | ) | (79,174 | ) | ||||
Interest and other income, net |
25,819 | 170,547 | ||||||
Income (loss) before benefit for income taxes |
(5,113,820 | ) | 91,373 | |||||
Provision (benefit) for income taxes |
(729,385 | ) | 92,479 | |||||
Net Loss |
$ | (4,384,435 | ) | $ | (1,106 | ) | ||
Loss per common and common equivalent shares |
||||||||
Basic |
$ | (0.07 | ) | $ | (0.00 | ) | ||
Diluted |
$ | (0.07 | ) | $ | (0.00 | ) | ||
Weighted average number of common and common equivalent shares outstanding |
||||||||
Basic |
62,524,446 | 61,920,094 | ||||||
Diluted |
62,524,446 | 61,920,094 |
TASER International, Inc.
Reconciliation of GAAP to Non-GAAP Financial Measures
(Unaudited)
Reconciliation of GAAP to Non-GAAP Financial Measures
(Unaudited)
For the Three Months Ended | For the Twelve Months Ended | |||||||||||||||
December 31, 2010 | December 31, 2009 | December 31, 2010 | December 31, 2009 | |||||||||||||
GAAP net sales |
$ | 22,881,512 | 34,502,925 | $ | 86,930,019 | 104,251,560 | ||||||||||
Trade-in program revenue deferral |
| (3,465,650 | ) | | | |||||||||||
Adjusted revenues |
$ | 22,881,512 | 31,037,275 | $ | 86,930,019 | 104,251,560 | ||||||||||
GAAP gross margin |
$ | 11,838,260 | 21,766,979 | $ | 45,366,875 | 63,402,409 | ||||||||||
Trade-in program revenue deferral |
| (3,465,650 | ) | | | |||||||||||
Adjusted gross margin |
$ | 11,838,260 | 18,301,329 | $ | 45,366,875 | 63,402,409 | ||||||||||
GAAP Income (Loss) from operations |
$ | (30,522 | ) | 7,223,488 | $ | (5,139,639 | ) | (79,174 | ) | |||||||
Trade-in program revenue deferral |
| (3,465,650 | ) | | | |||||||||||
Stock-based compensation expense (a) |
843,677 | 1,206,656 | 3,682,675 | 4,988,837 | ||||||||||||
Depreciation and amortization |
2,043,690 | 1,226,142 | 7,286,915 | 3,634,412 | ||||||||||||
Adjusted operating income |
$ | 2,856,845 | 6,190,636 | $ | 5,829,951 | 8,544,075 | ||||||||||
a) | Results include stock-based compensation as follows: |
For the Three Months Ended | For the Twelve Months Ended | |||||||||||||||
December 31, 2010 | December 31, 2009 | December 31, 2010 | December 31, 2009 | |||||||||||||
Cost of products sold |
$ | 75,090 | 88,726 | $ | 300,787 | 349,243 | ||||||||||
Sales, general and administrative expenses |
513,350 | 777,558 | 2,728,360 | 3,218,736 | ||||||||||||
Research and development expenses |
255,237 | 340,372 | 653,528 | 1,420,858 | ||||||||||||
$ | 843,677 | 1,206,656 | $ | 3,682,675 | 4,988,837 | |||||||||||
TASER International, Inc.
Consolidated Balance Sheets
(Unaudited)
Consolidated Balance Sheets
(Unaudited)
December 31, 2010 | December 31, 2009 | |||||||
Assets |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 42,684,241 | $ | 45,505,049 | ||||
Accounts receivable, net of allowance of $200,000 in 2010 and 2009, respectively |
13,542,535 | 15,384,993 | ||||||
Inventory |
17,815,405 | 15,085,750 | ||||||
Prepaid expenses and other assets |
1,999,525 | 1,461,539 | ||||||
Deferred income tax assets, net |
6,284,489 | 8,447,915 | ||||||
Total current assets |
82,326,195 | 85,885,246 | ||||||
Property and equipment, net |
35,905,765 | 38,673,065 | ||||||
Deferred income tax assets, net |
13,919,753 | 10,997,093 | ||||||
Intangible assets |
3,090,876 | 2,765,701 | ||||||
Other long-term assets |
944,346 | 104,812 | ||||||
Total assets |
$ | 136,186,935 | $ | 138,425,917 | ||||
Liabilities and stockholders equity |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 4,550,789 | $ | 6,357,195 | ||||
Accrued liabilities |
3,759,800 | 4,252,577 | ||||||
Current portion of deferred revenue |
3,265,260 | 2,819,155 | ||||||
Customer deposits |
372,145 | 355,926 | ||||||
Total current liabilities |
11,947,994 | 13,784,853 | ||||||
Deferred revenue, net of current portion |
4,392,860 | 4,675,089 | ||||||
Liability for unrecognized tax benefits |
2,281,840 | 2,264,779 | ||||||
Total liabilities |
18,622,694 | 20,724,721 | ||||||
Stockholders equity |
||||||||
Preferred stock, $0.00001 par value per share; 25 million shares authorized;
no shares issued and outstanding at December 31, 2010 and 2009 |
| | ||||||
Common stock, $0.00001 par value per share; 200 million shares authorized;
62,621,268 and 62,119,063 shares issued and outstanding at December 31, 2010
and 2009, respectively |
647 | 642 | ||||||
Additional paid-in capital |
97,122,085 | 92,839,165 | ||||||
Treasury stock, 2,091,600 shares at December 31, 2010 and 2009 |
(14,708,237 | ) | (14,708,237 | ) | ||||
Retained earnings |
35,185,191 | 39,569,626 | ||||||
Accumulated other comprehensive income/(loss) |
(35,445 | ) | | |||||
Total stockholders equity |
117,564,241 | 117,701,196 | ||||||
Total liabilities and stockholders equity |
$ | 136,186,935 | $ | 138,425,917 | ||||
TASER International, Inc.
Selected Consolidated Statement of Cash Flows Information
(Unaudited)
Selected Consolidated Statement of Cash Flows Information
(Unaudited)
For the Twelve Months Ended | ||||||||
December 31, 2010 | December 31, 2009 | |||||||
Net loss |
$ | (4,384,435 | ) | $ | (1,106 | ) | ||
Depreciation and amortization |
7,286,915 | 3,634,412 | ||||||
Stock-based compensation expense |
3,682,675 | 4,988,837 | ||||||
Net cash provided by operating activities |
783,673 | 10,117,286 | ||||||
Net cash used by investing activities |
(4,471,703 | ) | (11,679,875 | ) | ||||
Net cash provided by financing activities |
877,246 | 187,203 | ||||||
Cash and cash equivalents, end of period |
$ | 42,684,241 | $ | 45,505,049 |